Tracking the IMDX option chain helps you see every strike and expiry on Insight Molecular Diagnostics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Insight Molecular Diagnostics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of IMDX options activity at a glance. Use our scanner to monitor the IMDX option chain in real time and filter for the IMDX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For IMDX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the IMDX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where IMDX stock options are being actively traded and where they are not.
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system.
OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Insight Molecular Diagnostics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen IMDX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of IMDX stock options — let the full option chain come to you, pre-filtered and ready to trade.
